Differential activity of cremophor EL and paclitaxel in patients' tumor cells and human carcinoma cell lines in vitro

This publication has 19 references indexed in Scilit:

• Comparison of solutol HS 15, cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents
  International Journal of Cancer, 1995
• Paclitaxel (Taxol)
  New England Journal of Medicine, 1995
• The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL
  British Journal of Cancer, 1995
• Phase I trial of cremophor EL and doxorubicin in advanced cancer
  Anti-Cancer Drugs, 1994
• Up-regulation of ?-glutamylcysteine synthetase activity in melphalan-resistant human multiple myeloma cells expressing increased glutathione levels
  Cancer Chemotherapy and Pharmacology, 1994
• The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol®) in human tumor cell lines
  Cancer Chemotherapy and Pharmacology, 1994
• Paclitaxel-induced cytotoxicity—the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoprotein
  European Journal Of Cancer, 1994
• Measurement of Cremophor EL Following Taxol: Plasma Levels Sufficient to Reverse Drug Exclusion Mediated by the Multidrug-Resistant Phenotype
  JNCI Journal of the National Cancer Institute, 1993
• The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance
  British Journal of Cancer, 1990
• Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation
  Blood, 1989